Kevin Shannon - Concepedia

Author

Kevin Shannon

Also Known As

K P Shannon, K Shannon, K. P. SHANNON, K. P. Shannon, K. SHANNON, K. Shannon, K.P Shannon, K.P. Shannon, KEVIN SHANNON, Kevin P. Shannon

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

St Thomas' Hospital King's College London King's College Hospital

About

Kevin Shannon is an author at St Thomas' Hospital specializing in antimicrobial resistance, medicine, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	31	1.9K
2	Health Sciences	16	20	912
3	Engineering	1	1	45
4	Natural Sciences	1	1	13
5	Public Health	1	1	260

Kevin Shannon

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination G.L. French, Jonathan A. Otter, Kevin Shannon, Journal of Hospital Infection Methicillin-resistant Staphylococcus AureusMicrobial ContaminationDecontaminationHealthcare-associated InfectionHospital Environment	2004	403
Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes David M. Livermore, Trevor Winstanley, Kevin Shannon Journal of Antimicrobial Chemotherapy GeneticsGenetic EpidemiologyFurther AntibioticsAntibiotic ResistanceNon-host Resistance	2001	260
Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase G.L. French, Kevin Shannon, N.A. Simmons Journal of Clinical Microbiology Cardiac SurgeryMedical MicrobiologyAntimicrobial SusceptibilityHealth SciencesAntibiotics	1996	170
Understanding Antibacterial Action and Resistance Kevin Shannon Journal of Hospital Infection MedicineAntibacterial ActionAntibacterial AgentAntimicrobial TherapyMicrobiology	1996	150
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli Paul Stapleton, P J Wu, Anna King, Antimicrobial Agents and Chemotherapy	1995	144
Carbapenem Resistance in <i>Escherichia coli</i> Associated with Plasmid-Determined CMY-4 β-Lactamase Production and Loss of an Outer Membrane Protein Paul Stapleton, Kevin Shannon, G.L. French Antimicrobial Agents and Chemotherapy	1999	127
A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure M. MacRae, Kevin Shannon, Diana Rayner, Journal of Hospital Infection Neonatal UnitAntibioticsHealth SciencesKlebsiella PneumoniaeHealthcare-associated Infection	2001	94
In vitro antibacterial activity of norfloxacin (MK-0366) Anna King, Christine Warren, Kevin Shannon, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyDrug ResistanceCommon BacteriaVitro Antibacterial ActivityBeta-lactam Antibiotics	1982	80
The <i>in-vitro</i> activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid Anna King, Kevin Shannon, Ian Phillips Journal of Antimicrobial Chemotherapy	1984	80
Distribution of Genes for Trimethoprim and Gentamicin Resistance in Bacteria and their Plasmids in a General Hospital Naomi Datta, SANDRA DACEY, Valerie Hughes, Microbiology	1980	72

Page 1